Metformin and Muscle in Insulin-resistant Older Veterans

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT01804049

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose other
Phase
Phase 1/2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01804049
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01804049. Randomized; double masking; primary purpose other. Start 2014-04-08 (actual); primary completion 2018-08-31 (actual). Results posted on 2020-02-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin and Muscle in Insulin-resistant Older Veterans
Acronym
M&M
Condition
Prediabetes
Intervention (Drug)
metformin
Intervention (Drug)
placebo
Lead sponsor
VA Office of Research and Development (class: US federal agency)
Collaborator
Oregon Health and Science University (class: other)

Record details

Record id
cardio:ct-nct01804049
Content hash
cf7e7c6e83aec90ae13672db40094ba3a96b4a2c5a3a114adccd0303cb4a0177